Topic: --NEW-- Oligometastatic PCa: treating the primary and/or metastases
Earn accreditation points
Finish 5 cases, answer 10 questions and Earn 1 credit.
This topic consists of 5 cases
Disease Area: Prostate cancer
Background: Oligometastatic prostate cancer (OMPC) is a heterogeneous disease state which is poorly understood and of which the clinical implications are unclear. In this topic, the location of the metastases does not rule out metastasis-directed therapy.
Educational Objective: Gain insight into the factors deciding on local therapy of the primary and metastasis-directed therapy.
Specialty: Urology, medical oncology, radiation oncology
Target Audience: CME (intermediate-advanced) Residents (senior)
Latest update: June 2019